Increased cerebral oxygen consumption in Eker rats and effects of N-methyl-D-aspartate blockade: Implications for autism

Journal of Neuroscience Research

Volumn 85, Issue 11, 2007, Pages 2512-2517

  Weiss, Harvey R ^a   Liu, Xia ^a   Zhang, Qihang ^a   Chi, Oak Z ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Autism spectrum disorder; Cerebral blood flow; Cerebral O2 consumption; Excitatory amino acids; Rats

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENAZONE I 125;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTISM; BRAIN OXYGEN CONSUMPTION; CONTROLLED STUDY; DRUG MECHANISM; MALE; MICROSPECTROPHOTOMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ANIMALS; AUTISTIC DISORDER; BLOTTING, WESTERN; BRAIN; CEREBROVASCULAR CIRCULATION; EXCITATORY AMINO ACID ANTAGONISTS; MALE; OXYGEN CONSUMPTION; PIPECOLIC ACIDS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; TUBEROUS SCLEROSIS;

EID: 34547639716     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21378     Document Type: Article

References (39)

1. Aldred S, Moore KM, Fitzgerald M, Waring RH. 2003. Plasma amino acid levels in children with autism and their families. J Autism Dev Disord 33:93-97.
2. Allen G, Muller RA, Courchesne E. 2004. Cerebellar function in autism: functional magnetic resonance image activation during a simple motor task. Biol Psych 56:269-278.
3. Blatt GJ, Fitzgerald CM, Guptill JT, Booker AB, Kemper TL, Bauman ML. 2001. Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J Autism Dev Disord 31:537-543.
4. 2 supply and consumption determined microspectrophotometrically. Am J Physiol 253:H454-H560.
5. Carlsson ML. 1998. Hypothesis: is infantile autism a hypoglutamatergic disorder? Relevance of glutamate-serotonin interactions for pharmacotherapy. J Neur Transmiss 105:525-535.
6. Chen PE, Wyllie DJ. 2006. Pharmacological insights obtained from structure-function studies of ionotropic glutamate receptors. Br J Pharmacol 147:839-853.
7. Chi OZ, Anwar M, Sinha AK, Weiss HR. 1991. Effects of MK-801 on cerebral regional oxygen consumption in focal cerebral ischemia in rats. Circ Res 69:414-420.
8. Chi OZ, Liu X, Weiss HR. 2003. Effects of inhibition of neuronal nitric oxide synthase on NMDA-induced changes in cerebral blood flow and oxygen consumption. Exp Brain Res 148:256-260.
9. Curatolo P, Porfirio MC, Manze B, Seri S. 2004. Autism in tuberous sclerosis. Eur J Paediatr Neurol 8:327-332.
10. Gerlai R, Gerlai J. 2004. Autism: a target of pharmacotherapies? Drug Discov Today 9:366-374.
11. Haddad JJ. 2005. N-methyl-D-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways: a revolving neurochemical axis for therapeutic intervention? Prog Neurobiol 77:252-282.
12. Haznedar MM, Buchsbaum MS, Hazlett EA, LiCalzi ,EM, Cartwright C, Hollander E. 2006. Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disorders. Am J Psychiat 163:1252-1263.
13. Herold S, Frackowiak RS, Le Couteur A, Rutter M, Howlin P. 1988. Cerebral blood flow and metabolism of oxygen and glucose in young autistic adults. Psych Med 18:823-831.
14. Jamain S, Betancur C, Quach H, Philippe A, Fellous M, Giros B, Gillberg C, Leboyer M, Bourgeron T. 2002. Paris Autism Research International Sibpair (PARIS) Study. Linkage and association of the glutamate receptor 6 gene with autism. Mol Psychiatry 7:302-310.
15. Johnston MV. 2005. Excitotoxicity in perinatal brain injury. Brain Pathol 15:234-240.
16. Kaya M, Karasalihoglu S, Ustun F, Gultekin A, Cermik TF, Fazlioglu Y, Ture M, Yigitbasi ON, Berkarda S. 2002. The relationship between 99mTc-HMPAO brain SPECT and the scores of real life rating scale in autistic children. Brain Dev 24:77-81.
17. Kwon CH, Luikart BW, Powell CM, Zhou J, Matheny SA, Zhang W, Li Y, Baker SJ, Parada LF. 2006. Pten regulates neuronal arborization and social interaction in mice. Neuron 50:377-388.
18. Lewis JC, Thomas HV, Murphy KC, Sampson JR. 2004. Genotype and psychological phenotype in tuberous sclerosis. J Med Genet 41:203-207.
19. Minervini M, Atlante A, Gagliardi S, Ciotti MT, Marra E, Calissano P. 1997. Glutamate stimulates 2-deoxyglucose uptake in rat cerebellar granule cells. Brain Res 768:57-62.
20. Mizuno A, Villalobos ME, Davies MM, Dahl BC, Muller RA. 2006. Partially enhanced thalamocortical functional connectivity in autism. Brain Res 1104:160-174.
21. Moore ML, Eichner SF, Jones JR. 2004. Treating functional impairment of autism with selective serotonin-reuptake inhibitors. Ann Pharmacother 38:1515-1519.
22. Murcia CL, Gulden F, Herrup K. 2005. A question of balance: a proposal for new mouse models of autism. Int J Dev Neurosci 23:265-275.
23. Nakamichi N, Oikawa H, Kambe Y, Yoneda Y. 2004. Relevant modulation by ferrous ions of N-methyl-D-aspartate receptors in ischemic brain injuries. Curr Neurovasc Res 1:429-440.
24. Nayate A, Bradshaw JL, Rinehart NJ. 2005. Autism and Asperger's disorder: are they movement disorders involving the cerebellum and/or basal ganglia? Brain Res Bull 67:327-334.
25. Nilsson M, Carlsson A, Markinhuhta KR, Sonesson C, Pettersson FM, Gullme M, Carlsson ML. 2004. The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition. Prog Neuropsychopharmacol Biol Psychiatry 28:677-685.
26. Polleux F, Lauder JM. 2004. Toward a developmental neurobiology of autism. Mental Retard Dev Disab Res Rev 10:303-317.
27. Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J. 2001. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 57:1618-1628.
28. Rumsey JM, Duara R, Grady C, Rapoport JL, Margolin RA, Rapoport SI, Cutler NR. 1985. Brain metabolism in autism. Resting cerebral glucose utilization rates as measured with positron emission tomography. Arch Gen Psychiatry 42:448-455.
29. Schmitz N, Rubia K, Daly E, Smith A, Williams S, Murphy DG. 2006. Neural correlates of executive function in autistic spectrum disorders. Biol Psychiatry 59:7-16.
30. Serajee FJ, Zhong H, Nabi R, Huq AH. 2003. The metabotropic glutamate receptor 8 gene at 7q31: partial duplication and possible association with autism. J Med Genet 40:e42.
31. Sharkey J, Ritchie IM, Butcher SP, Kelly JS. 1996 Comparison of the patterns of altered cerebral glucose utilisation produced by competitive and noncompetitive NMDA receptor antagonists. Brain Res 735:67-82.
32. Shibata S, Tominaga K, Hamada T, Watanabe S. 1992. Excitatory effect of N-methyl-D-aspartate and kainate receptor on the 2-deoxyglucose uptake in the rat suprachiasmatic nucleus in vitro. Neurosci Lett 13:983-986.
33. Shuang M., Liu J, Jia MX, Yang JZ, Wu SP, Gong XH, Ling YS, Ruan Y, Yang YL, Zhang D. 2004. Family-based association study between autism and glutamate receptor 6 gene in Chinese Han trios. Am J Med Genet 13:48-50.
34. +/- cells. Oncogene 21:4050-4059.
35. Volkmer FR, Pauls D. 2003. Autism. Lancet 362:1133-1141.
36. 2 consumption. Brain Res 951:177-182.
37. Wilcox J, Tsuang MT, Ledger E, Algeo J, Schnurr T. 2002. Brain perfusion in autism varies with age. Neuropsychobiol 46:13-16.
38. Wiznitzer M. 2004. Autism and tuberous sclerosis. J Child Neurol 19:675-679.
39. Zhu N, Weiss HR. 1991. Oxy- and carboxyhemoglobin saturation in frozen small vessels. Am J Physiol 260:H626-H631.